2023
High-Level Drug-Resistant Mutations among HIV-1 Subtype A6 and CRF02_AG in Kazakhstan
Sanaubarova A, Pujol-Hodge E, Dzissyuk N, Lemey P, Vermund S, Brown A, Ali S. High-Level Drug-Resistant Mutations among HIV-1 Subtype A6 and CRF02_AG in Kazakhstan. Viruses 2023, 15: 1407. PMID: 37515095, PMCID: PMC10384832, DOI: 10.3390/v15071407.Peer-Reviewed Original ResearchConceptsAntiretroviral therapySubtype A6Drug-resistant mutationsDrug resistanceEffective antiretroviral therapySuppressive antiretroviral therapyAntiretroviral drug resistanceDrug resistance monitoringHigh-level drug resistanceDrug regimensHIV incidenceHIV epidemicHIV-1Sustained transmissionMolecular epidemiologySubtypesPLHIVHIVG190SDifferent mutational pathwaysMutationsK101ED67NHigh levelsA62V
2007
Seroincidence of Recent Human Immunodeficiency Virus Type 1 Infections in China▿
Xiao Y, Jiang Y, Feng J, Xu W, Wang M, Funkhouser E, Vermund SH, Jia Y. Seroincidence of Recent Human Immunodeficiency Virus Type 1 Infections in China▿. MSphere 2007, 14: 1384-1386. PMID: 17671229, PMCID: PMC2168114, DOI: 10.1128/cvi.00356-06.Peer-Reviewed Original Research